Explore the expanded oncology capabilities of Taconic Biosciences and TransCure bioServices, now part of Taconic. By combining advanced genetically engineered and humanized mouse platforms with translational in vivo pharmacology, immune profiling, imaging, and biomarker analysis, we provide integrated support from model selection and cohort generation through preclinical study execution.
June 8-11, 2026 | Budapest, Hungary | Taconic Biosciences | TransCure bioServices
Advancing Translational Oncology Through Humanized and Genetically Engineered Research Solutions
Join Taconic Biosciences and TransCure bioServices in Budapest at the European Association for Cancer Research (EACR) 2026 Congress to explore how advanced oncology models, humanized platforms, and integrated pharmacology capabilities support translational cancer research and therapeutic development.
Connect with our scientific teams to discuss how translationally aligned research strategies can help improve study design, strengthen confidence in preclinical findings, and support more informed oncology drug development decisions.
View:
Select One
- Research Expertise
- Scientific Posters
- Meet the Team
Integrated Humanized Models, In Vivo Pharmacology, and Translational Expertise
Scientific Posters
We are proud to share that Taconic will present the following posters at the 2026 conference.
Tuesday, June 9, 2026 | 10:30 - 20:00 | Tumor Biology
Robust multiplex cytokine profiling in second-generation humanized NOG mice using a 41-plex humanized mouse immune panel: Cross-donor validation and implications for translational oncology studies
Presented by Mette Harboe, Taconic Biosciences
Wednesday, June 10, 2026 | 10:30 - 20:00 | Immunotherapy
Insights from orthotopic tumor engraftment in humanized immune system mice
Presented by TransCure bioServices
Wednesday, June 10, 2026 | 10:30 - 20:00 | Immunotherapy
Preclinical efficacy, safety, and biodistribution assessment of therapeutic candidates with humanized mouse models
Presented by TransCure bioServices
Wednesday, June 10, 2026 | 10:30 - 20:00 | Immunotherapy
Fully customizable humanized immune system mouse platforms for preclinical drug development
Presented by TransCure bioServices
Learn from Experience
Engage directly with scientists and Taconic leadership who understand the complexities of translational oncology research. Our team brings deep expertise in genetically engineered and humanized model platforms, and in vivo pharmacology execution. Whether you are refining study design, evaluating model selection, or planning next-phase experiments, we provide practical, data-driven guidance grounded in experience. Connect with us to discuss how to reduce translational uncertainty and design studies aligned to your therapeutic mechanism and development objectives.
Meet the Team
Julie Torvund-Jensen, PhD 
Associate Director, Strategic Portfolio Development
Mette Harboe, PhD
Scientific Solutions Consultant
Alexandru Codreanu
Associate Client Relationship Manager
30 min | Booth #1
Meet with an expert at the conference
Meet with Taconic scientists to evaluate in vivo model selection, study design, and translational considerations for gene and cell therapies.
Oncology Portfolio Highlights
Accelerate Your Next Discovery
Taconic scientists are available to help you navigate through model selection and design that best fit your research program. Complete the form to meet with an expert and discover how to accelerate your drug discovery pipeline.